Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9274 | 1103 | 44.1 | 83% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1555 | 6779 | XANOMELINE//MUSCARINIC RECEPTORS//TACRINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | XANOMELINE | Author keyword | 47 | 79% | 3% | 30 |
2 | ALCURONIUM | Author keyword | 24 | 82% | 1% | 14 |
3 | MUSCARINIC TOXIN | Author keyword | 23 | 76% | 1% | 16 |
4 | MUSCARINIC TOXINS | Author keyword | 19 | 80% | 1% | 12 |
5 | M 1 | Author keyword | 19 | 70% | 1% | 16 |
6 | MUSCARINIC ACETYLCHOLINE RECEPTOR 1 | Author keyword | 14 | 100% | 1% | 7 |
7 | W84 | Author keyword | 12 | 86% | 1% | 6 |
8 | BQCA | Author keyword | 9 | 83% | 0% | 5 |
9 | MUSCARINIC | Author keyword | 8 | 12% | 6% | 67 |
10 | M 5 | Author keyword | 8 | 75% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | XANOMELINE | 47 | 79% | 3% | 30 | Search XANOMELINE | Search XANOMELINE |
2 | ALCURONIUM | 24 | 82% | 1% | 14 | Search ALCURONIUM | Search ALCURONIUM |
3 | MUSCARINIC TOXIN | 23 | 76% | 1% | 16 | Search MUSCARINIC+TOXIN | Search MUSCARINIC+TOXIN |
4 | MUSCARINIC TOXINS | 19 | 80% | 1% | 12 | Search MUSCARINIC+TOXINS | Search MUSCARINIC+TOXINS |
5 | M 1 | 19 | 70% | 1% | 16 | Search M+1 | Search M+1 |
6 | MUSCARINIC ACETYLCHOLINE RECEPTOR 1 | 14 | 100% | 1% | 7 | Search MUSCARINIC+ACETYLCHOLINE+RECEPTOR+1 | Search MUSCARINIC+ACETYLCHOLINE+RECEPTOR+1 |
7 | W84 | 12 | 86% | 1% | 6 | Search W84 | Search W84 |
8 | BQCA | 9 | 83% | 0% | 5 | Search BQCA | Search BQCA |
9 | MUSCARINIC | 8 | 12% | 6% | 67 | Search MUSCARINIC | Search MUSCARINIC |
10 | M 5 | 8 | 75% | 1% | 6 | Search M+5 | Search M+5 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GALLAMINE | 90 | 66% | 8% | 84 |
2 | XANOMELINE | 84 | 76% | 5% | 58 |
3 | AGONIST XANOMELINE | 60 | 100% | 2% | 20 |
4 | M1 TOXIN | 41 | 100% | 1% | 15 |
5 | ANTIPSYCHOTIC LIKE ACTIVITY | 33 | 67% | 3% | 29 |
6 | ALCURONIUM | 31 | 67% | 3% | 28 |
7 | POSITIVE COOPERATIVE INTERACTIONS | 25 | 75% | 2% | 18 |
8 | SUBTYPE SELECTIVITIES | 24 | 91% | 1% | 10 |
9 | M 2 RECEPTORS | 22 | 67% | 2% | 20 |
10 | M 1 RECEPTOR | 21 | 85% | 1% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Positive allosteric modulators of the mu-opioid receptor: a novel approach for future pain medications | 2015 | 5 | 83 | 16% |
Allosteric modulation of G protein-coupled receptors: A pharmacological perspective | 2011 | 91 | 74 | 53% |
Muscarinic acetylcholine receptors: novel opportunities for drug development | 2014 | 19 | 116 | 54% |
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders | 2009 | 101 | 40 | 70% |
Muscarinic acetylcholine receptors as CNS drug targets | 2008 | 166 | 103 | 53% |
Development of M-1 mAChR Allosteric and Bitopic Ligands: Prospective Therapeutics for the Treatment of Cognitive Deficits | 2013 | 15 | 141 | 75% |
M1 muscarinic acetylcholine receptor in Alzheimer's disease | 2014 | 10 | 119 | 52% |
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development | 2007 | 207 | 120 | 40% |
The Best of Both Worlds? Bitopic Orthosteric/Allosteric Ligands of G Protein-Coupled Receptors | 2012 | 54 | 113 | 35% |
Rational design of dualsteric GPCR ligands: quests and promise | 2010 | 41 | 75 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REBECCA L COOPER S | 7 | 26% | 2.1% | 23 |
2 | VANDERBILT NEUROSCI DRUG DISCOVERY | 6 | 19% | 2.5% | 28 |
3 | VANDERBILT PROGRAM DRUG DISCOVERY | 5 | 25% | 1.7% | 19 |
4 | DRUG DISCOVERY BIOL | 4 | 20% | 1.7% | 19 |
5 | SEZ CHIM FARMACEUT PIETRO PRATESI | 3 | 42% | 0.5% | 5 |
6 | SECT BIOCHEM PHARMACOL | 2 | 23% | 0.8% | 9 |
7 | BIOL TECHNOL IBITEC S | 2 | 67% | 0.2% | 2 |
8 | UNITE BIOTECHNOL SIGNALISAT CELLULAIRE | 2 | 67% | 0.2% | 2 |
9 | VANDERBILT PROGRAM DRUG DISCOVERY CHEM | 2 | 67% | 0.2% | 2 |
10 | VANDERBILT PROGRAM DRUG DISCOVERY PHARMACOL | 2 | 67% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000238366 | MUSCARINIC RECEPTOR SUBTYPES//MUSCARINIC RECEPTORS//PIRENZEPINE |
2 | 0.0000134878 | FP TZTP//IQNP//DEXETIMIDE |
3 | 0.0000117694 | BIOCHEM TECHNOL SCI TECHNOL//GPR35//RESONANT WAVEGUIDE GRATING BIOSENSOR |
4 | 0.0000099963 | M 3 MUSCARINIC ACETYLCHOLINE RECEPTOR//ACUTE CHOLINERGIC SYNDROME//BAOGONGTENG A |
5 | 0.0000086180 | NEOSTIGMINE//INTRATHECAL NEOSTIGMINE//HOSP CLINDISCIPLINE ANESTHESIOL |
6 | 0.0000085994 | GALBULIMIMA ALKALOIDS//GALBULIMIMA BELGRAVEANA//HIMBACINE |
7 | 0.0000084596 | RHODOPSIN//ZENTRUM BIOPHYS BIOINFORMAT//IONIC LOCK |
8 | 0.0000076629 | PHARMACOPERONE//MOL PHARMACOL GRP//BRET |
9 | 0.0000076341 | AGONIST AFFINITY//OPERATIONAL MODEL OF AGONISM//IRREVERSIBLE RECEPTOR INACTIVATION METHOD |
10 | 0.0000064397 | RHYTHMICAL CONTRACTIONS//SEROTONIN2A RECEPTORS//MOTILITY ANALYSIS |